Moradi Ghobad, Gouya Mohammad Mehdi, Eshrati Babak, Mohraz Minoo, Piroozi Bakhtiar
Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Centre for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Med J Islam Repub Iran. 2018 Aug 2;32:65. doi: 10.14196/mjiri.32.65. eCollection 2018.
Antimicrobial resistance (AMR) is one of the most important threats to health worldwide. Therefore, the World Health Organization (WHO) have invited countries around the world to work together to inhibit AMR, and all the member states are expected to prepare a national plan for tackling AMR by 2017. This project was aimed to prepare the National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance (NAP-IRIAMR) during 2016 to 2021. In this article, the literature and available documents were reviewed to identify key stakeholders. Moreover, interviews, brain storming sessions, and meetings with key stakeholders were held to determine NAP-IRIAMR objectives, strategies, policies, and indicators for monitoring and evaluation. To reach consensus and make a conclusion, participants' views and comments were analyzed using Delphi method and expert panel. In this national action plan for combating AMR, 13 key stakeholders were identified and 5 objectives were set: (1) raising public awareness and increasing trainings on AMR, (2) continuous monitoring of AMR, (3) preventing the spread of microorganisms resistant to antimicrobials, (4) promoting the rational use of antimicrobials, (5) promoting research and development in the field of AMR. The NAP-IRIAMR was prepared for the years 2016- 2021. Intersectoral cooperation is needed to combat AMR. It is expected that implementing the NAP-IRIAMR and reaching the determined goals will help overcome the problems related to AMR.
抗菌药物耐药性（AMR）是全球健康面临的最重要威胁之一。因此，世界卫生组织（WHO）邀请世界各国共同努力抑制AMR，并期望所有成员国在2017年前制定一项应对AMR的国家计划。该项目旨在制定2016年至2021年伊朗伊斯兰共和国抗击抗菌药物耐药性国家行动计划（NAP - IRIAMR）。在本文中，对文献和现有文件进行了审查以确定关键利益相关者。此外，还与关键利益相关者举行了访谈、头脑风暴会议和会议，以确定NAP - IRIAMR的目标、战略、政策以及监测和评估指标。为达成共识并得出结论，使用德尔菲法和专家小组对参与者的意见和评论进行了分析。在这项抗击AMR的国家行动计划中，确定了13个关键利益相关者并设定了5个目标：（1）提高公众对抗菌药物耐药性的认识并增加相关培训；（2）持续监测抗菌药物耐药性；（3）防止对抗菌药物耐药的微生物传播；（4）促进抗菌药物的合理使用；（5）促进抗菌药物耐药性领域的研究与开发。NAP - IRIAMR是为2016 - 2021年制定的。抗击AMR需要跨部门合作。预计实施NAP - IRIAMR并实现既定目标将有助于克服与抗菌药物耐药性相关的问题。
